Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondria as Therapeutic Targets in Heart Failure
Julia Schwemmlein, Christoph Maack, Edoardo Bertero
Current Heart Failure Reports (2022) Vol. 19, Iss. 2, pp. 27-37
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration
Edgar E. Nollet, Inez Duursma, Anastasiya Rozenbaum, et al.
European Heart Journal (2023) Vol. 44, Iss. 13, pp. 1170-1185
Open Access | Times Cited: 46
Mitochondrial Structure and Function in Human Heart Failure
Antentor Hinton, Steven M. Claypool, Kit Neikirk, et al.
Circulation Research (2024) Vol. 135, Iss. 2, pp. 372-396
Open Access | Times Cited: 27
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes
Raffaele Marfella, Lucia Scisciola, Nunzia D’Onofrio, et al.
Pharmacological Research (2022) Vol. 184, pp. 106448-106448
Open Access | Times Cited: 68
Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies
Nilanjan Ghosh, Leena Chacko, Hiranmoy Bhattacharya, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 29
Inflammation and Heart Failure: Searching for the Enemy—Reaching the Entelechy
Ioannis Paraskevaidis, Dimitrios Farmakis, Georgios Papingiotis, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 1, pp. 19-19
Open Access | Times Cited: 18
Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure
Isaac Giménez-Escamilla, Carlota Benedicto, Lorena Pérez-Carrillo, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 285-285
Open Access | Times Cited: 5
Formononetin ameliorates isoproterenol induced cardiac fibrosis through improving mitochondrial dysfunction
Qian Lei, Hu Xu, Ruqiang Yuan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116000-116000
Open Access | Times Cited: 12
Current understanding of structural and molecular changes in diabetic cardiomyopathy
Md Sayeed Akhtar, Sirajudeen Shaik Alavudeen, Asif Raza, et al.
Life Sciences (2023) Vol. 332, pp. 122087-122087
Closed Access | Times Cited: 11
Mitochondrial microRNAs Are Dysregulated in Patients with Fabry Disease
Jessica Gambardella, Antonella Fiordelisi, Daniela Sorriento, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 72-78
Open Access | Times Cited: 16
Metabolic Approaches for the Treatment of Dilated Cardiomyopathy
Roberto Spoladore, Giuseppe Pinto, Francesca Daus, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 7, pp. 287-287
Open Access | Times Cited: 9
SIRT6 mediated histone H3K9ac deacetylation involves myocardial remodelling through regulating myocardial energy metabolism in TAC mice
Shuqi Wu, Jiaojiao Zhang, Chang Peng, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 22, pp. 3451-3464
Open Access | Times Cited: 9
Activation of RXRα exerts cardioprotection through transcriptional upregulation of Ndufs4 in heart failure
Mingyan Shao, Lingru Li, Lin Ma, et al.
Science Bulletin (2024) Vol. 69, Iss. 9, pp. 1202-1207
Closed Access | Times Cited: 3
Energy metabolism: from physiological changes to targets in sepsis-induced cardiomyopathy
Dan Ni, Xiaofang Lin, Chuanhuan Deng, et al.
Hellenic Journal of Cardiology (2024) Vol. 80, pp. 96-106
Open Access | Times Cited: 3
Anti-ageing interventions for the treatment of cardiovascular disease
Mahmoud Abdellatif, Sophie T Schmid, Alexander Fuerlinger, et al.
Cardiovascular Research (2024)
Open Access | Times Cited: 3
Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
Chin‐Feng Hsuan, Sean I. F. Teng, Chih‐Neng Hsu, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 662-662
Open Access | Times Cited: 8
Giant mitochondria in cardiomyocytes: cellular architecture in health and disease
Amy Li, Gerald J. Shami, Lisa M. Griffiths, et al.
Basic Research in Cardiology (2023) Vol. 118, Iss. 1
Open Access | Times Cited: 8
Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets
Michele Correale, Lucia Tricarico, Francesca Croella, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Beyond Quadruple Therapy and Current Therapeutic Strategies in Heart Failure with Reduced Ejection Fraction: Medical Therapies with Potential to Become Part of the Therapeutic Armamentarium
Christos Kourek, Αlexandros Briasoulis, Adamantia Papamichail, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3113-3113
Open Access | Times Cited: 2
From Energy Metabolic Change to Precision Therapy: a Holistic View of Energy Metabolism in Heart Failure
Jianpei Wen, Chen Chen
Journal of Cardiovascular Translational Research (2023) Vol. 17, Iss. 1, pp. 56-70
Closed Access | Times Cited: 5
TRPC3-Nox2 Protein Complex Formation Increases the Risk of SARS-CoV-2 Spike Protein-Induced Cardiomyocyte Dysfunction through ACE2 Upregulation
Yuri Kato, Kazuhiro Nishiyama, Jae Man Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 102-102
Open Access | Times Cited: 8
Native skeletal muscle T1-time on cardiac magnetic resonance: A predictor of outcome in patients with heart failure with preserved ejection fraction
Christina Kronberger, Katharina Mascherbauer, Robin Willixhofer, et al.
European Journal of Internal Medicine (2024) Vol. 129, pp. 93-99
Open Access | Times Cited: 1
Heart Failure: A Deficiency of Energy—A Path Yet to Discover and Walk
Ioannis Paraskevaidis, Christos Kourek, Dimitrios Farmakis, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2589-2589
Open Access | Times Cited: 1
A century of mitochondrial research, 1922–2022
Howard T. Jacobs
˜The œEnzymes (2023), pp. 37-70
Closed Access | Times Cited: 3
Identification of key genes associated with heart failure based on bioinformatics analysis and screening of traditional Chinese medicines for the prevention and treatment of heart failure
Xu Luo, Rui Wang, Xin Zhang, et al.
Medicine (2023) Vol. 102, Iss. 49, pp. e35959-e35959
Open Access | Times Cited: 2
Circ-CIMIRC inhibition alleviates CIH-induced myocardial damage via FbxL4-mediated ubiquitination of PINK1
Runhua Wu, Fengsheng Xu, Jingyi Li, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108982-108982
Open Access
Page 1 - Next Page

Scroll to top